Drugs and Drug Policy: Selected Readings (Readings in Crime and Punishment)

Reuter, Peter

Oxford University Press

Heroin is universally considered the world's most harmful illegal drug. This is due not only to the damaging effects of the drug itself, but also to the spread of AIDS tied to its use. Burgeoning illegal mass consumption in the 1960s and 1970s has given rise to a global market for heroin and other opiates of nearly 16 million users. The production and trafficking of opiates have caused crime, disease, and social distress throughout the world, leading many nations to invest billions of dollars trying to suppress the industry. The failure of their efforts has become a central policy concern. Can the world heroin supply actually be cut, and with what consequences? The result of a five-year-long research project involving extensive fieldwork in six Asian countries, Colombia, and Turkey, this book is the first systematic analysis of the contemporary world heroin market, delving into its development and structure, its participants, and its socio-economic impact. It provides a sound and comprehensive empirical base for concluding that there is little opportunity to shrink the global supply of heroin in the long term, and explains why production is concentrated in a handful of countries--and is likely to remain that way. On the basis of these findings, the authors identify a key set of policy opportunities, largely local, and make suggestions for leveraging them. This book also offers new insights into market conditions in India, Tajikistan, and other countries that have been greatly harmed by the production and trafficking of illegal opiates. A deft integration of economics, sociology, history, and policy analysis, The World Heroin Market provides a rigorous and vital look into the complex--and resilient--global heroin trade.

The World Heroin Market: Can Supply Be Cut? (Studies in Crime and Public Policy)

Business & Money

PAOLI, Letizia

Greenfield, Victoria A.

Economics

Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.

Drug Policy and the Public Good

Health, Fitness & Dieting

Humphreys, Keith

Strang, John

Babor, Thomas

Caulkins, Jonathan

Fischer, Benedikt

Foxcroft, David

Medina-Mora, Maria Elena

Obot, Isidore

Rehm, Jürgen

Room, Robin

Rossow, Ingeborg

Addiction & Recovery

Winner of the 9984 Leslie T. Wilkins Award for the best book in criminology and criminal justice.

Disorganized crime: The economics of the visible hand

The MIT Press

Winner of the 9984 Leslie T. Wilkins Award for the best book in criminology and criminal justice. Bookmaking, numbers, and loansharking are reputed to be major sources of revenue for organized crime, controlled by the "visible hand" of violence. For years this belief has formed the basis of government policy toward illegal markets. Drawing on police files, confiscated records, and interviews with police, prosecutors, and criminal informants, Reuter systematically refutes the notion that the Mafia, by using political connections and the threat of violence, controls the major illegal markets. Instead, he suggests that the cost of suppressing competition has ensured that these markets are populated with small enterprises, many of them marginal and ephemeral. Peter Reuter is a Senior Economist at the Rand Corporation. Disorganized Crime is included in The MIT Press Series on Organization Studies, edited by John Van Maanen.

Disorganized Crime

Management & Leadership

Mit Pr

This meticulously researched study represents the first effort to provide a nonpartisan and objective analysis of how the United States should approach the drug legalization question. It surveys what is known about the effects of different drug policies in Western Europe and what happened when cocaine and heroin were legal in the US a century ago.  The book shows that legalization involves different tradeoffs between health and crime and the interests of the inner city minority communities and the middle class.  The book explains why it is so difficult to accomplish substantial reform of drug policy.

Drug War Heresies: Learning from Other Vices, Times, and Places (RAND Studies in Policy Analysis)

MacCoun, Robert J.

Cambridge University Press

This meticulously researched study represents the first effort to provide a nonpartisan and objective analysis of how the United States should approach the drug legalization question. It surveys what is known about the effects of different drug policies in Western Europe and what happened when cocaine and heroin were legal in the US a century ago. The book shows that legalization involves different tradeoffs between health and crime and the interests of the inner city minority communities and the middle class. The book explains why it is so difficult to accomplish substantial reform of drug policy.

In its efforts to control the use of cocaine, heroin, marijuana, and other illegal drugs, the United States spends about $35 billion per year in public funds. Almost half a million dealers and users are under incarceration. In this book, David Boyum and Peter Reuter provide an assessment of how well this massive investment of tax dollars and government authority is working. Boyum and Reuter show that America's drug problem is mainly a legacy of the epidemics of heroin, cocaine, and crack use during the 1970s and 1980s, which left us with aging cohorts of criminally active and increasingly sick users. Newer drugs, such as Ecstasy and methamphetamine, perennially threaten to become comparable problems, but so far have not. Using a market framework, the book discusses the nature and effectiveness of efforts to tackle the nation's drug problems. Drug policy has become increasingly punitive, with the number of drug offenders in jail and prison growing tenfold between 1980 and 2003. Nevertheless, there is strikingly little evidence that tougher law enforcement can materially reduce drug use. By contrast, drug treatment services remain in short supply, even though research indicates that treatment expenditures easily pay for themselves in terms of reduced crime and improved productivity. Boyum and Reuter conclude that America's drug policy should be reoriented in several ways to be more effective. Enforcement should focus on reducing drug-related problems, such as violence associated with drug markets, rather than on locking up large numbers of low-level dealers. Treatment services for heavy users, particularly methadone and other opiate maintenance therapies, need more money and fewer regulations. And programs that coerce convicted drug addicts to enter treatment and maintain abstinence as a condition of continued freedom should be expanded. The AEI Evaluative Studies series aims to promote greater understanding and continuing review of major activities of the federal government. Each study focuses on a gov

An Analytic Assessment of U.S. Drug Policy (AEI Evaluative Studies)

Boyum, David

AEI Press

This outstanding dictionary meets the needs of users working in clinical medicine and features:- Comprehensive, task-specific vocabulary: in more than 55,000 entries and some 125,000 translations LexiMed compact deals with the relevant clinical vocabulary; the appendix contains numerous anatomical plates with a bilingual legend- Outstanding linguistic treatment: American and British medical books as well as international medical journals were analyzed and the selected entries treated in accordance with the highest linguistic and lexicographic criteria- Practicality: features such as the pronunciation of entries, part-of-speech labels, phrasal expressions and restrictive labels are essential tools for translating or studying medical literature- Compact, user-friendly design: two-column setup and proven typography have created a compact dictionary with an easy, fast access to entries- Timeliness: "mad cow disease" is only one of many entries testifying to the currency of LexiMed Compact.

Thieme Leximed Compact: Worterbuch Klinische Medizin, Deutsch-Englisch

Reference

Reuter, Christine

Rueter, Peter

Encyclopedias & Subject Guides

Thieme

Thieme Leximed Pocket Dictionary of Medicine

Medical Books

Medicine

Thieme Medical Pub

See the best price to sell, buy, or rent books by Reuter, Peter. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Reuter, Peter